Biological medicines

PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor Injection

When patients with non-myeloid malignancies receive antitumor therapy that inhibits bone marrow with clinically meaningful febrile neutropenia, this drug reduces the incidence of infections caused by febrile neutropenia. This product is not used for mobilization of peripheral blood progenitor cells from hematopoietic stem cell transplantation.